The University of Chicago Header Logo

Connection

Samuel Refetoff to Tumor Burden

Back to Details
This is a "connection" page, showing publications Samuel Refetoff has written about Tumor Burden.
Samuel Refetoff
Connection Strength
0.027
Tumor Burden
  1. Obatoclax overcomes resistance to cell death in aggressive thyroid carcinomas by countering Bcl2a1 and Mcl1 overexpression. Endocr Relat Cancer. 2014 Oct; 21(5):755-67.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.